Nona Bio Forms Collab with Invetx for Animal Health Biotherapeutics
03 Feb 2025 //
PR NEWSWIRE
Invetx Announces Upcoming Acquisition By Dechra Pharmaceuticals
18 Jul 2024 //
BUSINESSWIRE
Invetx’s Research Study Reveals 40% of Dogs in U.S. Suffer from Pain
29 Nov 2023 //
BUSINESSWIRE
Invetx Completes Development of Canine and Feline Half-Life Extension Platform
25 Jul 2023 //
BUSINESSWIRE
Invetx Appoints Dr. Marcus Remmers to Board of Directors
26 Jun 2023 //
BUSINESSWIRE
Twist, Invetx Partner to Treat Multiple Diseases in Cats and Dogs
18 Nov 2021 //
BUSINESSWIRE
Boehringer & Invetx Collaborate to Advance MAb Biotherapeutics in Animal Health
27 Sep 2021 //
BUSINESSWIRE
Invetx Announces Initiation of First Clinical Study in Dogs with IVX-01
20 Sep 2021 //
BUSINESSWIRE
Invetx Announces Completion of $25.5 Million Series A Financing
30 Sep 2020 //
BUSINESSWIRE
Invetx Announces Completion of $25.5 Million Series A Financing
29 Sep 2020 //
BUSINESSWIRE
Twist Bioscience Partners with Invetx to Deliver Best-in-Class Antibody
16 Jul 2020 //
BUSINESSWIRE